Ketamine for Depression in Newport Beach: A Physician's Guide to a Rapidly Changing Landscape

Depression in Newport Beach Can Look Different Than You Expect

Depression in Newport Beach does not always look like the statistics suggest. It may not look like someone who cannot get out of bed. Instead, it can look like someone who goes to work, runs the meeting, makes the dinner reservation, and then sits alone at the end of the day wondering why none of it feels meaningful.

It can look like high-functioning misery: successful by every visible measure, yet empty in ways that remain invisible to everyone around them.

This is a common presentation we see at Seaside Ketamine. For some patients, ketamine therapy may offer another treatment option when traditional antidepressants have not provided enough relief.

Why Antidepressants Often Aren’t Enough

Selective serotonin reuptake inhibitors (SSRIs) and SNRIs remain first-line treatments for major depressive disorder. They help many people, but they do not work for everyone.

Clinical research shows that roughly one-third of patients do not achieve remission after multiple antidepressant trials. Even among people who respond initially, symptoms may return over time. Some patients also experience medication side effects that make long-term treatment difficult.

After several unsuccessful antidepressant trials, clinicians may consider augmentation, medication changes, or combination therapy. These approaches can help, but many continue to target the serotonin or norepinephrine systems.

Ketamine works differently.

A Different Mechanism of Action

Ketamine primarily affects the glutamate system, including NMDA receptors, rather than working like traditional SSRIs and SNRIs.

This difference may help explain why ketamine can benefit some patients who have not responded adequately to conventional antidepressants. Researchers have also linked ketamine treatment to downstream changes involving synaptic connections and brain-derived neurotrophic factor (BDNF).

These effects may contribute to ketamine’s rapid antidepressant action. Some patients experience improvement within hours or days rather than waiting several weeks to see whether a traditional antidepressant will work.

However, response varies from person to person. Ketamine does not guarantee rapid or lasting relief for every patient.

What Does Treatment-Resistant Depression Actually Mean?

Clinicians generally use the term treatment-resistant depression (TRD) when major depressive disorder has not responded adequately to at least two antidepressant trials given at appropriate doses and for an appropriate duration.

For Newport Beach patients who have cycled through medications for months or years, their experience may fit this definition even if their current diagnosis does not include the term “treatment-resistant depression.”

Recognizing TRD can help patients and clinicians consider other evidence-based treatment options. These may include ketamine and esketamine (Spravato), depending on the patient’s diagnosis, medical history, and treatment goals.

Spravato: An FDA-Approved Option

Spravato (esketamine) is a prescription nasal spray derived from the S-enantiomer of ketamine. The FDA has approved Spravato for adults with treatment-resistant depression. It also has an indication for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior, alongside an oral antidepressant.

Unlike IV ketamine, Spravato follows an established FDA-approved treatment pathway and may offer an insurance coverage option for eligible patients.

Seaside Ketamine Newport Beach is a certified Spravato treatment site. If insurance coverage is important to you, our team can help review your coverage before your consultation.

What Does a Treatment Series Look Like?

IV ketamine treatment typically begins with a series of infusions. Many protocols use six treatments over approximately two to three weeks, with each infusion lasting about 40 to 60 minutes.

Patients can respond at different points in the initial series. Some notice changes early, while others require additional treatments before they recognize meaningful improvement. Dr. Gillin evaluates each patient’s response and can recommend an appropriate next step based on that response.

Spravato follows a different schedule. Patients typically receive treatment twice a week during the first four weeks. The schedule then decreases to once a week for another four weeks, followed by maintenance treatment once every one or two weeks based on the FDA-approved dosing schedule and the treating clinician’s assessment.

Patients remain at the clinic for monitoring after each Spravato administration. The required observation period lasts at least two hours.

What Can Newport Beach Patients Expect?

Our Newport Beach practice provides the same physician-led approach as our Cardiff location. Treatment begins with a comprehensive evaluation rather than a one-size-fits-all protocol.

Your care may include:

• A detailed psychiatric and medical history

• A personalized treatment plan

• Physician oversight

• IV ketamine or Spravato when clinically appropriate

• Support throughout the treatment process

• Follow-up to assess your response and determine next steps

If you have managed depression for years without finding the relief you hoped for, a conversation about ketamine may help you understand whether this approach fits your situation.